The role of blue light cystoscopy and additional operative evaluations during first surveillance after induction therapy for high-risk NMIBC
Blue light cystoscopy improves surveillance of HR-NMIBC, particularly in those with CIS. Additional restaging procedures improved detection of extravesical disease in patients with heavier pre-treatment history. Risk-adapted utilization of enhanced restaging procedures requires further study.
Authors
- Ryan L. Steinberg (ORCID: https://orcid.org/0000-0003-3558-0183)
- Michael A. O’Donnell (ORCID: https://orcid.org/0000-0001-7202-6427)
- Sarah L. Mott (ORCID: https://orcid.org/0000-0001-9381-2080)
- Ian M. McElree (ORCID: https://orcid.org/0000-0001-9991-4301)
- Helen Y. Hougen (ORCID: https://orcid.org/0000-0003-3141-6474)
- Vignesh T. Packiam (ORCID: https://orcid.org/0000-0001-8397-7797)
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Iowa (US)
Publication Details
- Journal
- Bladder Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1177/23523735251324318
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03